MEM 12.5% 0.7¢ memphasys limited.

Ann: FELIX System commercialisation, regulatory plan and trial, page-5

  1. 69 Posts.
    lightbulb Created with Sketch. 33
    Trial completion shift to 2023 is unfortunate.

    On the positive, company is actively working with different markets and provided tangible updates for Japan, Canada, US, India and China. Data from Monash trial so far appears to exceed clinical expectations.
 
watchlist Created with Sketch. Add MEM (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
-0.001(12.5%)
Mkt cap ! $9.679M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $505 72.14K

Buyers (Bids)

No. Vol. Price($)
3 263708 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 3584999 6
View Market Depth
Last trade - 13.27pm 19/07/2024 (20 minute delay) ?
MEM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.